Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
American Enterprise Institute
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Health policy studies=== {{primary sources|section|date=September 2024}} AEI scholars have engaged in health policy research since the institute's early days. A Center for Health Policy Research was established in 1974.<ref name="1981 AR">American Enterprise Institute, ''Annual Report'', 1981–82.</ref> For many years, [[Robert B. Helms]] led the health department. AEI's long-term focuses in health care have included [[national health insurance|national insurance]], [[Medicare (United States)|Medicare]], [[Medicaid]], [[pharmaceuticals|pharmaceutical innovation]], health care competition, and cost control.<ref name="Highlight"/> The center was replaced in the mid-1980s with the Health Policy Studies Program. The AEI Press has published dozens of books on health policy since the 1970s.{{citation needed|date=September 2024}} Since 2003, AEI has published the ''Health Policy Outlook'' series on new developments in U.S. and international health policy. AEI also published ''A Better Prescription'' in February 2010 to outline their ideal plan to healthcare reform, calling for putting the money and control in the hands of the consumers and continuing the market-based system of healthcare, a form of healthcare that "relies on financial incentives rather than central direction and control."<ref>{{Cite book |last1=Antos |first1=Joseph |url=https://www.aei.org/wp-content/uploads/2011/10/ABetterPrescription.pdf?x85095 |title=A Better Prescription |last2=P. Miller |first2=Thomas |date=23 February 2010 |publisher=American Enterprise Institute }}</ref> According to [[openDemocracy]], "In the late 1990s, while he was funded by the tobacco industry, [[Roger Bate|[AEI fellow Roger] Bate]] argued against the science which shows that exposure to tobacco causes cancer."<ref name="n551"/> Helms long argued against the tax break for [[employer-sponsored health insurance]], arguing that it distorts insurance markets and limits [[consumer choice]]s.<ref>{{cite book|last1=Cogan|first1=John F.|last2=Hubbard|first2=R. Glenn|author-link2=R. Glenn Hubbard|last3=Kessler|first3=Daniel P.|author-link3=Daniel P. Kessler|title=Healthy, Wealthy, and Wise: Five Steps to a Better Health Care System|publisher=AEI Press|year=2005|location=Washington|url=http://www.aei.org/book/831|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090610213220/http://www.aei.org/book/831|archive-date=June 10, 2009|url-status=dead}}</ref><ref>{{cite book|last=Glied|author-link1=Sherry Glied|first=Sherry|title=Revising the Tax Treatment of Employer-Provided Health Insurance|publisher=AEI Press|year=1994|location=Washington|url=http://www.aei.org/book/355|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090617074109/http://www.aei.org/book/355|archive-date=June 17, 2009|url-status=dead}}</ref><ref>{{cite book|editor-last=Helms|editor-first=Robert B.|title=American Health Policy: Critical Issues for Reform|publisher=AEI Press|year=1993|location=Washington|url=http://www.aei.org/book/10|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090610212558/http://www.aei.org/book/10|archive-date=June 10, 2009|url-status=dead}}</ref><ref>{{cite web|last=Helms|first=Robert B.|date=January 2005|title=Tax Reform and Health Insurance|periodical=Health Policy Outlook|publisher=American Enterprise Institute|url=http://www.aei.org/outlook/21921|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090613073930/http://www.aei.org/outlook/21921|archive-date=June 13, 2009|url-status=dead}} {{cite web|last=Dowd|first=Bryan E.|author-link=Bryan E. Dowd|date=September 2007|title=The Bush Administration's Health Insurance Tax Reform Proposal|periodical=Health Policy Outlook|publisher=American Enterprise Institute|url=http://www.aei.org/outlook/26768|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090613010535/http://www.aei.org/outlook/26768|archive-date=June 13, 2009|url-status=dead}} {{cite web|last=Helms|first=Robert B.|date=June 2009|title=Taxing Health Insurance: A Tax Designed to Be Avoided|periodical=Health Policy Outlook|publisher=American Enterprise Institute|url=http://www.aei.org/outlook/100046|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090617023942/http://www.aei.org/outlook/100046|archive-date=June 17, 2009|url-status=live}}</ref> [[Scott Gottlieb]], also a medical doctor, rejoined AEI after a term as commissioner with the [[Food and Drug Administration]].<ref name="ProPublica"/> He has expressed concern about relatively unreliable [[comparative effectiveness research]] being used to restrict treatment options under a public plan.<ref name="CER">{{cite web|last=Gottlieb|first=Scott|author-link=Scott Gottlieb|date=February 2009|title=Promoting and Using Comparative Research: What Are the Promises and Pitfalls of a New Federal Effort?|periodical=Health Policy Outlook|publisher=American Enterprise Institute|url=http://www.aei.org/outlook/100010|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090619150420/http://www.aei.org/outlook/100010|archive-date=June 19, 2009|url-status=live}}{{cite web|last1=Gottlieb|first1=Scott|last2=Klasmeier|first2=Coleen|date=June 2009|title=Comparative Effectiveness Research: The Need for a Uniform Standard|periodical=Health Policy Outlook|publisher=American Enterprise Institute|url=http://www.aei.org/outlook/100044|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090619150850/http://www.aei.org/outlook/100044|archive-date=June 19, 2009|url-status=live}}</ref>{{primary source inline|date=September 2024}} [[Roger Bate]]'s work includes international health policy, especially pharmaceutical quality, HIV/AIDS, malaria, and multilateral health organizations.{{citation needed|date=September 2024}} In 2008, [[Dora Akunyili]], then Nigeria's top drug safety official, spoke at an AEI event coinciding with the launch of Bate's book ''Making a Killing''.<ref name="MAK" /><ref>See conference information at {{cite web|url=http://www.aei.org/event/1700|title=AEI - Cracking Down on Killer Drugs: Dora Akunyili and the Nigerian Success Story|access-date=June 16, 2009|url-status=dead|archive-url=https://web.archive.org/web/20090620140701/http://www.aei.org/event/1700|archive-date=June 20, 2009}}</ref>{{primary source inline|date=September 2024}} [[Paul Ryan (politician)|Paul Ryan]], then-minority point man for health care in the House of Representatives, delivered the keynote address at a 2009 AEI conference on mandated universal coverage, insurance exchanges, the public plan option, medical practice and treatment, and revenue to cover federal health care costs.<ref>See conference information at {{cite web|url=http://www.aei.org/event/100070|title=AEI - the Five (Not So) Easy Pieces of Health Reform|access-date=June 16, 2009|url-status=dead|archive-url=https://web.archive.org/web/20090618065401/http://www.aei.org/event/100070|archive-date=June 18, 2009}}.</ref>{{primary source inline|date=September 2024}} In 2004, as [[Purdue Pharma]], a company known as the maker of [[OxyContin]], one of the many drugs abused in the [[opioid epidemic in the United States]], was facing a threat to its sales due to rising lawsuits against it, resident fellow [[Sally Satel]] wrote an op ed for the ''[[New York Times]]''. She commented, “When you scratch the surface of someone who is addicted to painkillers, you usually find a seasoned drug abuser with a previous habit involving pills, alcohol, heroin or cocaine. Contrary to media portrayals, the typical OxyContin addict does not start out as a pain patient who fell unwittingly into a drug habit.”<ref name="ProPublica"/> According to [[Associated Press|AP]], Satel "sometimes cited Purdue-funded studies and doctors in her articles on addiction for major news outlets and occasionally shared drafts of the pieces with Purdue officials in advance, including on occasions in 2004 and 2016." In 2018, she was hired by [[JD Vance]]'s charity, [[Our Ohio Renewal]], to a residency in Ohio. When this was criticised because of her ties to Purdue, Satel said she “never consulted with” or “took a cent from Purdue” and didn’t know Purdue had donated money to AEI.<ref name="c638">{{cite web | last=Smyth | first=Julie Carr | title=Vance's anti-drug charity enlisted doctor echoing Big Pharma | website=AP News | date=18 August 2022 | url=https://apnews.com/article/2022-midterm-elections-entertainment-health-175153d8a80d93b2c9c6654a6a730de9 | access-date=9 September 2024}}</ref> After undergoing a [[kidney transplant]] in 2006,<ref>{{cite web|last=Satel|first=Sally|author-link=Sally Satel|date=December 16, 2007|title=Desperately Seeking a Kidney|periodical=[[The New York Times Magazine]]|url=http://www.aei.org/article/27236|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090617194413/http://www.aei.org/article/27236|archive-date=June 17, 2009|url-status=dead}}</ref> Satel expanded her work from [[drug addiction]] treatment and [[mental health]] to include studies of compensation systems that she argues would increase the supply of organs for transplant.<ref>{{cite book|editor-last=Satel|editor-first=Sally|editor-link=Sally Satel|title=When Altruism Isn't Enough: The Case for Compensating Kidney Donors|publisher=AEI Press|year=2009|location=Washington|url=http://www.aei.org/book/970|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090615104227/http://www.aei.org/book/970|archive-date=June 15, 2009|url-status=dead}}</ref> In addition to their work on pharmaceutical innovation and [[Food and Drug Administration|FDA]] regulation, Gottlieb and John E. Calfee have examined [[vaccine]] and [[antiviral drug]] supplies in the wake of the [[2009 flu pandemic]].<ref>{{cite web|last=Gottlieb|first=Scott|date=May 2009|title=Vaccine Readiness in a Time of Pandemic: Policy Promises Realized and the Challenges That Remain |periodical=Health Policy Outlook|publisher=American Enterprise Institute|url=http://www.aei.org/outlook/100033|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090619150111/http://www.aei.org/outlook/100033|archive-date=June 19, 2009|url-status=live}} {{cite web|last=Calfee|first=John E.|date=June 2009|title=And Now, a Few Words about Antivirals for Pandemic Flu|periodical=Health Policy Outlook|publisher=American Enterprise Institute|url=http://www.aei.org/outlook/100040|access-date=June 16, 2009|archive-url=https://web.archive.org/web/20090610085649/http://www.aei.org/outlook/100040|archive-date=June 10, 2009|url-status=live}}</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
American Enterprise Institute
(section)
Add topic